Drugs / Analgecine
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02168010 | Oct 2013 → Jul 2014 | — | VanWorld Pharmaceutical (Rugao) Company Limited | Completed | No outcome recorded |
| Phase 3 | NCT02633618 | Aug → Dec 2005 | neuropathy, painful | VanWorld Pharmaceutical (Rugao) Company Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Analgecine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02168010 ↗ |
| Route | Other | “continuous infusion” NCT02633618 ↗ |